Vita Life Sciences Limited
ASX:VLS.AX
2.1 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | |||||||||||||||||
Current Assets: | |||||||||||||||||
Cash & Cash Equivalents
| 24.63 | 15.688 | 15.893 | 14.477 | 10.478 | 10.941 | 9.965 | 9.411 | 9.734 | 9.158 | 8.973 | 5.017 | 3.632 | 0.456 | 1.076 | 1.293 | 0.616 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 24.63 | 15.688 | 15.893 | 14.477 | 10.478 | 10.941 | 9.965 | 9.411 | 9.734 | 9.158 | 8.973 | 5.017 | 3.632 | 0.456 | 1.076 | 1.293 | 0.616 |
Net Receivables
| 11.215 | 8.977 | 7.117 | 6.942 | 7.76 | 7.093 | 6.662 | 6.234 | 6.482 | 6.041 | 4.73 | 4.481 | 3.285 | 8.086 | 2.803 | 2.145 | 1.929 |
Inventory
| 11.153 | 15.41 | 11.31 | 7.127 | 6.838 | 6.132 | 5.176 | 5.421 | 6.593 | 5.012 | 6.008 | 5.612 | 3.701 | 3.44 | 2.501 | 2.535 | 1.965 |
Other Current Assets
| 1.291 | 0.473 | 0.306 | 0.254 | 0.263 | 0.189 | 0.215 | 0.242 | 0.309 | 0.188 | 0.132 | 0.087 | 0.074 | 0.084 | 0.065 | 0.061 | 0.064 |
Total Current Assets
| 48.289 | 41.157 | 35.103 | 29.191 | 25.76 | 24.797 | 22.308 | 21.749 | 23.524 | 20.809 | 20.491 | 15.579 | 10.926 | 12.227 | 6.603 | 6.216 | 4.655 |
Non-Current Assets: | |||||||||||||||||
Property, Plant & Equipment, Net
| 9.17 | 8.472 | 8.264 | 8.372 | 9.139 | 8.642 | 9.409 | 9.381 | 7.629 | 6.91 | 0.369 | 0.199 | 0.193 | 0.223 | 0.193 | 0.303 | 0.274 |
Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 0.026 | 0.01 | 0 | 0.012 | 0.012 | 0.071 | 0.06 | 0.076 | 0.086 | 0.097 | 0 | 0 | 0 | 0 | 0 | 0 | 0.073 |
Goodwill and Intangible Assets
| 0.026 | 0.01 | 0 | 0.012 | 0.012 | 0.071 | 0.06 | 0.076 | 0.086 | 0.097 | -0.21 | 0 | 0 | 0 | 0 | 0 | 0.073 |
Long Term Investments
| -2.348 | -2.17 | 0 | -1.541 | -1.614 | 1.043 | 0.947 | 0.925 | 0.937 | 1.044 | 1.022 | 0.947 | 1.678 | 1.537 | 1.469 | 1.45 | 0.014 |
Tax Assets
| 2.322 | 2.16 | 1.903 | 1.529 | 1.602 | 1.167 | 0.223 | 0.205 | 0.207 | 1.411 | 0.127 | 0.088 | 0.088 | 0.047 | 0.056 | 0.048 | 0.073 |
Other Non-Current Assets
| 2.348 | 2.17 | 0 | 1.541 | 1.614 | 0 | 0.007 | 0.023 | 0.005 | 0 | 0.21 | 0 | 0.465 | 0.478 | 0.49 | 0.623 | 1.64 |
Total Non-Current Assets
| 11.518 | 10.642 | 10.167 | 9.913 | 10.753 | 10.923 | 10.646 | 10.61 | 8.864 | 9.462 | 1.518 | 1.234 | 2.424 | 2.286 | 2.207 | 2.424 | 2.074 |
Total Assets
| 59.807 | 51.799 | 45.27 | 39.104 | 36.513 | 35.72 | 32.954 | 32.359 | 32.388 | 30.271 | 22.009 | 16.813 | 13.349 | 14.512 | 8.81 | 8.641 | 6.729 |
Liabilities & Equity: | |||||||||||||||||
Current Liabilities: | |||||||||||||||||
Account Payables
| 5.579 | 4.495 | 3.819 | 3.088 | 2.526 | 2.563 | 2.455 | 1.287 | 2.849 | 1.929 | 1.986 | 2.423 | 2.267 | 2.685 | 1.945 | 2.164 | 1.33 |
Short Term Debt
| 0.211 | 0.3 | 0.19 | 0.617 | 0.644 | 0.342 | 0.29 | 0.279 | 0.243 | 0.26 | 0 | 0 | 0 | 1.814 | 1.321 | 1.278 | 0.818 |
Tax Payables
| 0.225 | 0.129 | 1.173 | 1.177 | 0.466 | 0.67 | 1.042 | 2.022 | 0.458 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 4.095 | 3.899 | 6.937 | 5.308 | 4.371 | 3.766 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 6.331 | 6.166 | 3.515 | 4.025 | 4.575 | 4.722 | 3.334 | 5.281 | 3.777 | 3.345 | 3.698 | 2.999 | 2.098 | 1.879 | 1.625 | 1.337 | 1.697 |
Total Current Liabilities
| 16.216 | 14.86 | 14.461 | 13.038 | 12.116 | 11.393 | 6.079 | 6.847 | 6.869 | 5.534 | 5.684 | 5.422 | 4.365 | 6.377 | 4.891 | 4.779 | 3.845 |
Non-Current Liabilities: | |||||||||||||||||
Long Term Debt
| 0.176 | 0.301 | 0.183 | 1.455 | 1.705 | 1.732 | 1.927 | 2.181 | 2.567 | 3.094 | 0 | 0 | 0 | 0 | 0.013 | 0.009 | 0 |
Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 1.099 | 0.766 | -0.666 | 0.504 | -0.914 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 0 | 0.071 | 0.07 | 0.075 | 0.074 | 0.052 | 0.051 | 0.021 | 0.009 | 0.009 | 0.008 | 0.008 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 0.084 | 0.135 | 0.132 | 0.098 | 0.083 | -0.985 | -0.663 | 0.771 | -0.449 | 0.983 | 0.047 | 0.041 | 0.02 | 0.005 | 0.005 | 0.008 | 0.005 |
Total Non-Current Liabilities
| 0.26 | 0.436 | 0.386 | 1.623 | 1.863 | 1.92 | 2.082 | 2.337 | 2.643 | 3.172 | 0.056 | 0.049 | 0.028 | 0.005 | 0.019 | 0.016 | 0.005 |
Total Liabilities
| 16.476 | 15.296 | 14.847 | 14.661 | 13.979 | 13.313 | 8.161 | 9.184 | 9.512 | 8.706 | 5.74 | 5.471 | 4.393 | 6.382 | 4.909 | 4.795 | 3.849 |
Equity: | |||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 42.567 | 41.904 | 41.633 | 41.593 | 42.249 | 43.742 | 44.498 | 44.692 | 44.911 | 45.429 | 46.1 | 45.956 | 45.568 | 45.69 | 45.699 | 44.55 | 44.28 |
Retained Earnings
| -2.769 | -8.482 | -12.528 | -17.925 | -22.046 | -23.243 | -19.789 | -20.59 | -21.863 | -24.307 | -29.623 | -33.532 | -35.355 | -36.297 | -40.757 | -40.428 | -40.45 |
Accumulated Other Comprehensive Income/Loss
| 3.599 | 3.152 | 1.648 | 1.053 | 2.396 | 1.876 | 0.049 | -0.969 | -0.222 | 0.347 | -0.298 | -1.168 | -1.722 | -1.742 | -1.531 | -0.898 | -1.427 |
Other Total Stockholders Equity
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Shareholders Equity
| 43.397 | 36.574 | 30.753 | 24.721 | 22.599 | 22.375 | 24.758 | 23.133 | 22.826 | 21.469 | 16.179 | 11.256 | 8.491 | 7.651 | 3.411 | 3.223 | 2.403 |
Total Equity
| 43.331 | 36.503 | 30.423 | 24.443 | 22.534 | 22.407 | 24.793 | 23.175 | 22.876 | 21.565 | 16.269 | 11.342 | 8.956 | 8.13 | 3.901 | 3.846 | 2.88 |
Total Liabilities & Shareholders Equity
| 59.807 | 51.799 | 45.27 | 39.104 | 36.513 | 35.72 | 32.954 | 32.359 | 32.388 | 30.271 | 22.009 | 16.813 | 13.349 | 14.512 | 8.81 | 8.641 | 6.729 |